| Application no. and date | 08847680.9 (espacenet) (Federated) (European Patent Register), 20081105 | | Patent/reg. no. and date | DK/EP 2219452, 20151014 | | Publication date | 20100825 | | Priority no. and date | US 996175 P, 20071105, US 100454 P, 20080926 | | EP pub. no. and date |
EP 2219452 20100825 | | Effective date | | | Applicant/owner | AstraZeneca AB,
151 85 Södertälje, SE | | Applicant ref. no. | MedImmune IFNAR-710EP1 | | Inventor | COYLE, Anthony, 1155 23rd Street
Washington, DC 20037, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | | Opponent | | | IPC Class | A01N 43/54 (2006.01) , A61K 39/395 (2006.01) , C07K 16/24 (2006.01) | | Title | FREMGANGSMÅDER TIL BEHANDLING AF SCLERODERMA. | | Int. application no. | US2008082481 | | Int. publication no. | WO2009061818 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
